Cag was Idexx Laboratories’s largest segment in fiscal 2025, bringing in $3.95B of $4.30B (92%).
| Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cag | $3.06B | $3.35B | $3.57B | $3.95B | |||||||||||||
| Cag Segment Revenue | — | — | — | — | |||||||||||||
| Companion Animal Group | — | — | — | — | |||||||||||||
| Lpd Segment Revenue | — | — | — | — | |||||||||||||
| Lpd | $122.61M | $121.66M | $122.06M | $131.79M | |||||||||||||
| Water Segment Revenue | $155.72M | $168.15M | $185.11M | $201.15M | |||||||||||||
| Water | — | — | — | — | |||||||||||||
| Livestock & Poultry Diagnostics Segment Revenue | — | — | — | — | |||||||||||||
| Other | — | — | — | — | |||||||||||||
| Other Revenue | — | $18.79M | $16.29M | $17.48M | |||||||||||||
| Other Segment Revenue | $30.20M | — | — | — | |||||||||||||
| Cag/Lpd Segment Transition | — | — | — | — | |||||||||||||
| Total | $3.37B | $3.66B | $3.90B | $4.30B |
Idexx Laboratories brought in $4.30B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 10.4% from $3.90B in fiscal 2024. Cag was the largest at $3.95B (91.9%), ahead of Water Segment Revenue at $201.15M (4.7%) and Lpd at $131.79M (3.1%). The remaining segment, Other Revenue, brought in $17.48M.
Compared with fiscal 2024, Cag grew fastest, up 10.6% to $3.95B. Every segment above 2% of revenue grew.
Idexx Laboratories began breaking out Other Revenue in fiscal 2023, when it brought in $18.79M. Idexx Laboratories stopped reporting Other Segment Revenue as a separate segment after fiscal 2022, when it brought in $30.20M.
Product Revenue was Idexx Laboratories’s largest product and service line in fiscal 2025, bringing in $2.54B of $4.30B (59%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | $1.93B | $2.09B | $2.25B | $2.54B | ||||||
| Service Revenue | $1.44B | $1.57B | $1.65B | $1.76B | ||||||
| Total | $3.37B | $3.66B | $3.90B | $4.30B |
Idexx Laboratories brought in $4.30B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 10.4% from $3.90B in fiscal 2024. Product Revenue was the largest at $2.54B (59.0%), ahead of Service Revenue at $1.76B (41.0%).
Compared with fiscal 2024, Product Revenue grew 12.9% to $2.54B and Service Revenue grew 7.0% to $1.76B. From fiscal 2022 to 2025, combined revenue from these lines grew from $3.37B to $4.30B, a compound annual growth rate of 8.5%. Product Revenue's share of the total rose from 57.3% to 59.0%.
Americas was Idexx Laboratories’s largest region in fiscal 2017, bringing in $1.33B of $1.97B (68%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Americas | $952.76M | $1.08B | $1.20B | $1.33B | |||||
| Europe, The Middle East & Africa | $366.39M | $348.33M | $375.76M | $419.42M | |||||
| Asia Pacific Region | $166.66M | $169.25M | $196.27M | $215.38M | |||||
| Total | $1.49B | $1.60B | $1.78B | $1.97B |
Idexx Laboratories brought in $1.97B from its three regions in fiscal 2017, the year ended December 31, 2017. That was up 10.9% from $1.78B in fiscal 2016. Americas was the largest at $1.33B (67.8%), ahead of Europe, The Middle East & Africa at $419.42M (21.3%) and Asia Pacific Region at $215.38M (10.9%).
Compared with fiscal 2016, Europe, The Middle East & Africa grew fastest, up 11.6% to $419.42M. Every region above 2% of revenue grew. From fiscal 2014 to 2017, combined revenue from these regions grew from $1.49B to $1.97B, a compound annual growth rate of 9.8%. Americas' share of the total rose from 64.1% to 67.8%.
Idexx Laboratories (IDXX) reports its revenue by segment, by product and service and by geography. In fiscal 2025, Cag was its largest segment, bringing in $3.95B (91.9% of the total), followed by Water Segment Revenue at $201.15M (4.7%).
Cag was Idexx Laboratories' largest segment in fiscal 2025, bringing in $3.95B, or 91.9% of the $4.30B total across its four segments.
Product Revenue was Idexx Laboratories' largest product and service line in fiscal 2025, bringing in $2.54B, or 59.0% of the $4.30B total across its two product and service lines.
Americas was Idexx Laboratories' largest region in fiscal 2017, bringing in $1.33B, or 67.8% of the $1.97B total across its three regions.
Among Idexx Laboratories' segments that make up at least 2% of revenue, Cag grew fastest in fiscal 2025, up 10.6% from $3.57B to $3.95B.
Every figure comes from Idexx Laboratories' annual financial filings, as reported. Each line keeps the name Idexx Laboratories gives it, and years follow its fiscal calendar.
Idexx Laboratories' revenue by segment goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.